Introduction
The filamentous, soil-inhabiting, Gram-positive bacterial genus Streptomyces is characterized by its ability to produce a wide variety of secondary metabolites including antibiotics and biologically active substances. We have studied the A-factor regulatory cascade that leads to secondary metabolite formation and morphological differentiation in Streptomyces griseus [1] . Grixazone, consisting of grixazone A (see Fig. 2 for its structure) and grixazone B (in which the aldehyde group of grixazone A is replaced by a carboxyl group) showing a parasiticide activity [2] , is one of the secondary metabolites under the control of A-factor [3] . The grixazone biosynthesis gene cluster contains 13 genes [4] , including griI-griH and griEgriF (Fig. 1A) . griI and griH encode an aldolase and 3-dehydroquinate synthase homologues, respectively. griEgriF are homologous to melC1-melC2 of streptomycetes, in which melC1 and melC2 encode a tyrosinase cofactor and a tyrosinase, respectively. We previously characterized these four genes and revealed two enzymatic reactions involved in grixazone biosynthesis (see Fig. 2 ), both of which had been unpredictable only on the basis of protein homology. One is the GriI-GriH reaction responsible for the formation of 3-amino-4-hydroxybenzoic acid (3,4-AHBA) from two primary metabolites, L-aspartate-4-semialdehyde and dihydroxyacetone phosphate [5] . The other is the GriE-GriF reaction responsible for the formation of the phenoxazinone chromophore of grixazones from two molecules of 3-amino-4-hydroxybenzaldehyde (3,4-AHBAL) [6] . These findings predicted that an enzyme(s) catalyzing the reduction of 3,4-AHBA to produce 3,4-AHBAL might be involved in grixazone biosynthesis and the enzyme gene(s) would be encoded in the gene cluster.
In this study, we identified griC and griD responsible for reduction of 3,4-AHBA to produce 3,4-AHBAL. griC encodes an AMP-binding protein, and griD encodes a protein exhibiting sequence similarity to some aldehyde dehydrogenases. Although griC-griD homologues have been found in other gene clusters, including those for biosynthesis of phenazine antibiotic D-alanylgriseoluteic acid in Erwinia herbicola [7] and a b -lactam antibiotic carbapenem, thienamycin, in Streptomyces cattleya [8] , their functions have not been elucidated. Here we report that GriC-GriD are essential for grixazone biosynthesis and constitute a carboxylic acid reductase that reduces 3,4-AHBA to 3,4-AHBAL. In addition to the GriCGriD function, we found that griG encoding a benzoate transporter homologue in the grixazone biosynthesis gene cluster had an apparently important role for efficient import of exogenously added 3,4-AHBA, although it was nonessential for grixazone biosynthesis.
Materials and Methods
Strains, Plasmids, Media, and Chemicals S. griseus IFO13350 was obtained from the Institute of Fermentation, Osaka, Japan. A natA null mutant (DnatA) of S. griseus was constructed previously [9] . S. griseus strains were grown at 30°C in YPD medium (0.2% yeast extract, 0.4% Bacto peptone, 0.5% NaCl, 0.2% MgSO 4 · 7H 2 O, 1.0% glucose, and 0.5% glycine, pH 7.2) or at 26.5°C in standard minimal medium [SMM; 0.9% glucose, 0.9% asparagine, 0.2% (NH 4 ) 2 SO 4 , 0.24% Trizma base, 0.1% NaCl, 0.05% K 2 SO 4 , 0.02% MgSO 4 · 7H 2 O, 0.01% CaCl 2 , 2.5 mM KH 2 PO 4 , and 1.0% trace element solution [10] , pH 7.2]. For grixazone production, S. griseus cells were cultured for 5 days in SMM, the KH 2 PO 4 concentration of which was 0.25 mM to allow expression of the grixazone biosynthesis genes [4] . We referred to the standard (2.5 mM KH 2 PO 4 ) and low-phosphate (0.25 mM KH 2 PO 4 ) SMM media as SMM-2.5 and SMM-0.25, respectively. SMM-2.5 was used for bioconversion experiments. A thiostrepton resistance plasmid pIJ702 containing the melC promoter [11] , with its copy number of 40 to 300 [10] , was used for DNA manipulation and gene expression in S. griseus. The melC promoter is active in the late exponential and stationary growth phases. Escherichia coli strains JM109, JM110, TOP10 (Invitrogen), and BL21 [pGro7] (Takara Biochemicals) and plasmids pUC19, pCR4Blunt-TOPO (Invitrogen), and pCold III (Takara Biochemicals) were used for DNA manipulation in E. coli. Restriction enzymes, T4 DNA ligase, Pyrobest DNA polymerase, and other DNA-modifying enzymes were purchased from Takara Biochemicals. 3,4-AHBAL, 3-acetylamino-4-hydroxybenzoic acid (3,4-AcAHBA), and 3-acetylamino-4-hydroxybenzaldehyde (3,4-AcAHBAL) were prepared as described previously [5, 6] . Other chemicals were purchased from Wako Chemicals. The absence of undesired alterations during PCR was checked by nucleotide sequencing.
Gene Disruption
The chromosomal griC, griD, and griG genes of S. griseus IFO13350 were disrupted as follows (Fig. 1A) . Correct disruption was checked by Southern hybridization (data not shown). A 1.1-kb fragment containing a 3Ј portion of griC and its downstream region was amplified by PCR with primers, 5Ј-TGGGAATTCGTCTACTGATGAGCACCGT-CGCAC-3Ј (with an EcoRI site shown by underlining and the stop codon of griC shown in italics) and 5Ј-CAC-GACGGTCTCCGGATCCCC-3Ј (with an inherent BamHI site shown by underlining). The amplified fragment was digested with EcoRI and BamHI, ligated with a 1.3-kb BamHI fragment containing a further downstream region from griC, and placed between the EcoRI and BamHI sites of pUC19. From the resulting plasmid, the 2.4-kb EcoRIHindIII fragment was excised and connected with a 3.4-kb BglII-EcoRI fragment containing a 5Ј portion of griC and (A) Gene organization of the grixazone biosynthesis gene cluster [4] and DNA fragments on plasmids used for gene disruption. its upstream region. This 5.8-kb fragment, which had a 1.0-kb in-frame deletion in griC (from Asp-10 to Gly-350 of GriC), was placed between the BamHI and HindIII sites of pUC19, together with a 1.1-kb HindIII fragment carrying the kanamycin/neomycin resistance gene from Tn5, resulting in pD griC. The plasmid was alkali-denatured and introduced by protoplast transformation into S. griseus IFO13350. Neomycin (5 m g/ml)-resistant transformants containing pD griC in the chromosome, as a result of a single crossover, were first isolated, and one of the transformants was cultured several times on YPD medium without neomycin. A neomycin sensitive colony was isolated as the true griC-disruptant (mutant DgriC). A 1.1-kb fragment containing a 5Ј portion of griD and its upstream region was amplified by PCR with primers, 5Ј-CGATGATCCCGAATTCGACAGTC-3Ј (with an inherent EcoRI site shown by underlining) and 5Ј-TGGTCTAGAG-TGCGACGGTGCTCATCAGTAGAC-3Ј (with an XbaI site shown by underlining and the start codon of griD shown in italics). The amplified fragment was digested with EcoRI and XbaI, and ligated with a 1.2-kb NcoI-EcoRI fragment containing a further upstream region from griD. This 2.3-kb NcoI-XbaI fragment was placed between the HindIII and XbaI sites of pUC19 using a short linker composed of HindIII-SphI-PstI-SalI-XbaI-BamHI-SmaI-NcoI sites. From the resulting plasmid, a 2.3-kb XbaI fragment was excised and used for further plasmid construction. On the other hand, a 0.9-kb fragment containing a 3Ј portion of griD and its downstream region was amplified by PCR with primers, 5Ј-TGGTCTAGACCCGGCGCTGACCCCTCCCG-3Ј (with an XbaI site shown by underlining and the stop codon of griD shown in italics) and 5Ј-TCAGGGCCGGATCCT-CGGGG-3Ј (with an inherent BamHI site shown by underlining). The amplified fragment was digested with XbaI and BamHI, and ligated with a 1.7-kb BamHI-NcoI fragment containing a further downstream region from griD. This 2.6-kb XbaI-NcoI fragment was placed between the XbaI and EcoRI sites of pUC19 using a short linker composed of NcoI-SmaI-KpnI-SacI-EcoRI sites. At the XbaI site of the resulting plasmid, the 2.3-kb XbaI fragment described above was placed in the correct orientation. This plasmid contained a deleted griD sequence, encoding a hexapeptide of the first 5 amino acids of GriD (Met-SerThr-Val-Ala) followed by Leu, with the 2.3-kb upstream and 2.6-kb downstream regions from griD. Finally, a 1.1-kb HindIII fragment carrying the kanamycin/neomycin resistance gene from Tn5 was placed at the HindIII site of the plasmid, resulting in pDgriD. By use of this plasmid, a griD-disruptant (mutant D griD) was similarly isolated by the method used for obtaining the griC-disruptant.
A 5.4-kb EcoRI-NcoI fragment containing a 5Ј portion of griG and its upstream region was connected with a 1. In this construct, griG was separated to two fragments that overlapped partially, from the 5Ј-terminus to position ϩ1030 (corresponding to the NcoI site) and from position ϩ857 (corresponding to the SphI site) to the 3Ј-terminus, by the kanamycin/neomycin resistance gene inserted. The plasmid, pgriG::Km r , was digested with DraI, alkali-denatured, and introduced by protoplast transformation into S. griseus. A neomycinresistant transformant, as a result of double crossover between the disrupted griG sequence and the intact chromosomal griG sequence, was isolated as the true griGdisruptant (mutant griG::Km r ).
Construction of Plasmids
A 0.5-kb fragment containing the melC promoter and the 5Ј-portion (173 bp) of melC1 was amplified by PCR using pIJ702 as a template and primers, 5Ј-CTGCAGAAGCT-TGAATTCTGATCACGTCAGTTTTC-3Ј (with a HindIII site and an EcoRI site shown by underlining) and 5Ј-AAGCTTCTGCAGTTGTAGATCTCGTCGAAG-3Ј (with a PstI site and an inherent BglII site shown by underlining). The amplified fragment, which contained an SphI site (GCATGC) overlapping with the start codon of melC1 shown by underlining, was digested with HindIII plus PstI and cloned into pUC19, resulting in pUC702. This plasmid was used for the construction of expression plasmids in S. griseus, pIJ702-griG and pIJ702-griCDG.
The 0.5-kb EcoRI-BglII fragment excised from pUC702 was placed between the BglII and EcoRI sites of a pIJ702-derived plasmid, in which the melC1-melC2 sequence under the melC promoter was replaced by a short linker containing SphI, BglII, and EcoRI sites, resulting in pIJ702-melC1Ј (Fig. 1B) . This plasmid was used as a negative control plasmid. The griG sequence was amplified by PCR using primers, 5Ј-CATGTACGCAGTACTCGCC-3Ј (with the start codon of griG shown in italic) and 5Ј-CTCGAGAGATCTTCAACGAGTTCTGCCTG-3Ј (with the stop codon of griG shown in italic and a BglII site shown by underlining). The amplified fragment was digested with BglII and placed in pUC702, which had been digested with SphI, blunted with T4 DNA polymerase, and digested with BglII. From the resulting plasmid, a 1.7-kb EcoRI-BglII fragment containing the griG sequence under the melC promoter was excised and placed between the EcoRI and BglII sites of the pIJ702-derived plasmid, resulting in pIJ702-griG (Fig. 1B) .
The inherent co-translational griC-griD sequence was amplified by PCR using primers, 5Ј-GCATGCTCCTC-ATCGATGATC-3Ј (with the start codon of griC shown in italic and an SphI site shown by underlining) and 5Ј-AGATCTTCAGCGCCGGGCCACGAC-3Ј (with the stop codon of griD shown in italic and a BglII site shown by underlining). After the amplified fragment had been cloned into pCR4Blunt-TOPO, the griC-griD sequence was excised with SphI plus BglII and cloned into the pIJ702-derived plasmid. Between the BglII and NdeI sites of the resulting plasmid, a 2.7-kb BglII-NdeI fragment containing the griG sequence under the melC promoter from pIJ702-griG were placed, resulting in pIJ702-griCDG (see Fig.  1B ).
The griC-griD sequence was amplified by PCR using primers, 5Ј-GGAATTCCATATGAGCCTCATCGATG-3Ј (with the start codon of griC shown in italic and an NdeI site shown by underlining) and 5Ј-GCTCGAGTTAGC-GCCGGGCCACGAC-3Ј (with the stop codon of griD shown in italic and an XhoI site shown by underlining). After the amplified fragment had been cloned into pCR4Blunt-TOPO, the griC-griD sequence was excised with NdeI plus XhoI and cloned into pCold III for expression in E. coli, resulting in pCold-griCD. On this plasmid, griC and griD were under the control of the cspA promoter that is inducible by cold-shock.
Bioconversion Conditions
S. griseus cells were precultured at 30°C for 2 days in 100 ml of YPD liquid medium supplemented with 10 mg/ml thiostrepton. The mycelium (about 4 g wet weight) was harvested by centrifugation, washed twice, resuspended in 10 ml of SMM-2.5, and homogenized. A portion (100 ml) of the homogenized solution was inoculated to 100 ml of fresh SMM-2.5 and cultured at 26.5°C for 2 days (up to the late exponential phase), and then an aryl carboxylic acid was added at a final concentration of 10 mM. After the cells were further incubated for 1ϳ3 days, compounds in the culture broth were analyzed by reversed-phase highperformance liquid chromatography (HPLC), as described previously [6] . The aryl aldehydes produced were determined by liquid chromatography-electrospray ionization mass spectrometry, as described previously [5] , in reference to the authentic compounds available commercially. The amounts of the aryl aldehydes produced were determined by HPLC in reference to the authentic compounds.
The conditions for the conversion of 3,4-AHBA to 3,4-AHBAL in E. coli were as follows. The cells of E. coli BL21 [pCold-griCD and pGro7] ([ ] denotes plasmidcarrier state) were incubated at 37°C to an optical density 0.6 at 600 nm in LB medium supplemented with 50 mg/ml ampicillin and 20 mg/ml chloramphenicol, and then placed in a water bath at 15°C for 30 minutes. Isopropyl b -Dthiogalactopyranoside and L-arabinose were then added at final concentrations of 0.1 mM and 0.5 mg/ml, respectively, to allow the expression of griC-griD and the chaperon gene on pGro7. At the same time, 3,4-AHBA was also added at a final concentration 1 mM and the culture was further continued at 15°C for 24 hours.
Results and Discussion
GriC and GriD Are Both Required for Reduction of 3,4-AHBA to 3,4-AHBAL On the basis of our findings on grixazone biosynthesis [5, 6] , we assumed that a reductase catalyzing the reduction of 3,4-AHBA to 3,4-AHBAL should be encoded in the grixazone biosynthesis gene cluster. griD was the most probable candidate for the reductase gene, because GriD showed amino acid sequence similarity (about 30% identity) to some NAD(P)-dependent aldehyde dehydrogenases. The start codon of griD overlapped with the stop codon of griC, suggesting that these two genes were co-transcribed and co-translated. GriC showed sequence similarity to AMP-binding proteins, including the N-terminal AMP-binding domain of a CAR of Nocardia sp. [12, 13] . The Nocardia CAR has a reductase domain in the C-terminal portion and catalyzes the reduction of aryl carboxylic acids to the corresponding aldehydes through acyl-AMP formation, followed by NADPH-dependent reduction of the intermediate [12, 13] . This suggests that the Nocardia CAR is like a GriC-GriD fusion protein. The computer search predicted that GriC and GriD were functionally related, since GriC and GriD homologues are encoded adjacently on the chromosomes of various bacteria, such as SCO7115-SCO7114 in Streptomyces coelicolor A3(2) [14] , thnN-thnO in S. cattleya [8] , MAP3493-MAP3494 in Mycobacterium avium [15] , STH579-STH578 in Symbiobacterium thermophilum [16] , ehpF-ehpG in E. herbicola [7] , and Plu3307-Plu3306 in Photorhabdus luminescens [17] (the anterior genes encode GriC homologues and the posterior genes encode GriD homologues). We therefore expected that GriC and GriD would constitute a carboxylic acid reductase (Fig. 2) .
To reveal the functions of GriC and GriD in the grixazone biosynthesis, we constructed griC-and griDdisrupted strains. Mutant D griC has an in-frame deletion of the region corresponding to Asp-10 to Gly-350 of GriC. In mutant D griD, the chromosomal griD sequence corresponding to Pro-6 to Ala-454 was replaced by a short linker, resulting in production of only the first five amino acids of GriD (Met-Ser-Thr-Val-Ala), followed by a Leu.
As we expected, D griC and D griD mutants produced no grixazone and accumulated detectable amounts of 3-acetylamino-4-hydroxybenzoic acid (3,4-AcAHBA) in the culture broth, when grown in SMM-0.25 at 26.5°C for 5 days (Fig. 3A) . SMM-0.25 contained a low concentration (0.25 mM) of KH 2 PO 4 to allow expression of the grixazone biosynthesis genes, because the gri genes are expressed under phosphate-depleted conditions [4] . Because 3,4-AcAHBA is a shunt product derived from 3,4-AHBA by an arylamine N-acetyltransferase (SgNAT) encoded by natA in S. griseus [9] , these observations implied that both mutants accumulated 3,4-AHBA. Note that both 3,4-AHBA and 3,4-AcAHBA were never detected in the culture broth of the wild-type S. griseus cells under grixazone-producing conditions [6] . The defect of grixazone production in mutants D griC and D griD was complemented by introduction of a low-copy number plasmid containing the intact griC-griD sequence with the griC promoter (data not shown).
We next examined bioconversion of 3,4-AHBA to 3,4-AHBAL by E. coli BL21 [pGro7] harboring pCold-griCD that contained a co-translational griC-griD sequence under the control of the cold-shock inducible cspA promoter on pCold III. When the production of GriC and GriD was initiated, 3,4-AHBA (final concentration, 1 mM) was added 384 Fig. 2 The proposed biosynthetic pathway leading to grixazone A and shunt products, 3,4-AcAHBA and 3,4-AcAHBAL.
Grixazone A is synthesized through the following three steps: (i) 3,4-AHBA production from two primary metabolites by GriI and GriH [5] , (ii) the reduction of 3,4-AHBA to 3,4-AHBAL by GriC-GriD (this study), and (iii) the formation of grixazone A in the presence of Nacetylcysteine by GriE and GriF [6] . A hypothetical pathway for reduction by GriC and GriD, on the basis of the sequence homology of GriC/GriD with the CAR of Nocardia [12] , is also shown. GriG is nonessential for grixazone biosynthesis but apparently contributes the uptake of 3,4-AHBA excreted and/or leaked from the cells (this study). 3,4-AcAHBA is produced from 3,4-AHBA by a cytosolic enzyme, SgNAT, encoded by natA in S. griseus [9] . SgNAT is also responsible for N-acetylation of 3,4-AHBAL to produce 3,4-AcAHBAL, but other acetyltransferase(s) must be involved in the N-acetylation (this study). ASA, L-aspartate 4-semialdehyde; and DHAP, dihydroxyacetone phosphate. 
